However, a high PTEN gene expression was associated with significantly shorter DSS (HR for breast cancer-specific death 2.06, 95% CI 1.08–3.01, p = 0.027) also for patients with primary metastatic disease (data not shown). This evidence concerns the gene PTEN and breast carcinoma.